CD40 Ligand and Neonatal Immune Response
Ramesh, Narayanaswamy
Children's Hospital Boston, Boston, MA, United States
Search 8 grants from Narayanaswamy Ramesh
Search grants from Children's Hospital Boston
Dissecting the role of dynamic epigenome prompting pathways leading to kidney allograft fibrosis
The Upper Midwestern Center of Excellence for Vector-Borne Disease
International Herpes Vaccine Project
Mechanisms of Vertebrate Gastrulation
Role of BDNF in nucleus accumbens in mood and motivation
Neonates are deficient in their ability to mount humoral immune responses. Although newborn lymphocytes are capable of eliciting specific antibodies in response to an antigenic challenge, the antibody responses are predominantly of the IgM class. In-vivo and in-vitro immune responses in newborn lymphocytes show a defect in isotype switching from IgM to IgG and IgA. The T cell surface molecule that delivers the contact-dependent signal for immunoglobulin isotype switching is the ligand for the B cell antigen CD4O (CD40 ligand, CD4OL). We have demonstrated that newborn lymphocytes express markedly decreased amounts of CD4OL and are severely deficient in their ability to undergo CD4OL-dependent immunoglobulin isotype switching to IgE. In the present proposal we wish to examine the molecular basis of the lack of CD40 ligand expression. We propose to Analyze CD4OL dependent isotype switching in infants. We will investigate the developmental regulation of CD4OL expression and assess the significance of reduced CD4OL expression by examining T cell directed IL-4 dependent IgE synthesis in infants versus adults. We will investigate whether delayed switching in transient hypogammaglobulinemia of infancy (THI) is associated with an abnormal delay in CD4OL expression. Analyze in detail transcriptional activation of the CD4OL gene. We propose to study the regulation of CD4OL expression in newborn T cells to understand the basis of their deficient expression of CD4OL. For that purpose, we will first determine the organization of the human CD4OL gene and characterize its upstream regulatory elements. c)Analyze the mechanism that lead to decreased CD4OL gene expression in cord blood T cells. We will examine whether low level expression of CD4OL in cord blood T cells is associated with altered methylation of the CD4OL gene upstream region. We will also analyze the cord blood T cells for the expression of trans-acting factors that regulate CD4OL expression. The results of our proposed studies should improve our understanding of the regulation of CD4OL expression in newborns and infants and may lead to the development of novel interventions that enhance isotype switching and of more effective vaccination regimens.
National Institute of Allergy and Infectious Diseases (NIAID)
First Independent Research Support & Transition (FIRST) Awards (R29)
5R29AI037130-04
Special Emphasis Panel (SRC (84))
Children's Hospital Boston
R29 AI CD40 Ligand and Neonatal Immune Response
Ramesh, Narayanaswamy / Children's Hospital Boston
Vaduva, G; Martinez-Quiles, N; Anton, I M et al. (1999) The human WASP-interacting protein, WIP, activates the cell polarity pathway in yeast. J Biol Chem 274:17103-8
Anton, I M; Lu, W; Mayer, B J et al. (1998) The Wiskott-Aldrich syndrome protein-interacting protein (WIP) binds to the adaptor protein Nck. J Biol Chem 273:20992-5
Kokron, C M; Bonilla, F A; Oettgen, H C et al. (1997) Searching for genes involved in the pathogenesis of primary immunodeficiency diseases: lessons from mouse knockouts. J Clin Immunol 17:109-26
Ramesh, N; Anton, I M; Hartwig, J H et al. (1997) WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. Proc Natl Acad Sci U S A 94:14671-6
Ramesh, N; Fuleihan, R; Swinton, P et al. (1995) A point mutation in exon 2 of the CD40 ligand gene causes the simultaneous expression of two defective mRNA species in X-linked hyperimmunoglobulinemia M. Hum Mol Genet 4:759-61
Be the first to comment on Narayanaswamy Ramesh's grant